Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.
A rogue B.C. acupuncturist has been found in contempt of court for practising unlicensed needlework. A B.C. Supreme Court ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback